Drugs of abuse and the adolescent athlete

Italian Journal of Pediatrics

Volumn 36, Issue 19, 2010, Pages

  Rogol, Alan D ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ERYTHROPOIETIN; HUMAN GROWTH HORMONE; INSULIN; MUSCLE PROTEIN; RECOMBINANT SOMATOMEDIN C; PERFORMANCE ENHANCING SUBSTANCE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C; TESTOSTERONE;

ACNE; ATHLETE; BODY COMPOSITION; DRUG ABUSE; FEMUR EPIPHYSIS; FLUID RETENTION; GLUCOSE TRANSPORT; GLYCOGENOLYSIS; HEADACHE; HIRSUTISM; HUMAN; HYPOGLYCEMIA; INTRACRANIAL HYPERTENSION; LEAN BODY WEIGHT; LIPOLYSIS; LIVER DYSFUNCTION; LUNG EMBOLISM; MENTAL DISEASE; MYALGIA; OVARY DISEASE; PROTEIN SYNTHESIS; REVIEW; SCOLIOSIS; SIDE EFFECT; ADDICTION; ADOLESCENT; ADOLESCENT DEVELOPMENT; DRUG EFFECT; MALE; PREVALENCE; STATISTICS; UNITED STATES; BODY HEIGHT; DOPING;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ATHLETES; HUMANS; MALE; PREVALENCE; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 77949823228     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/1824-7288-36-19     Document Type: Review

References (22)

1. Malina RM, Bouchard C, Bar-Or O: The young athlete. Growth, maturation and physical activity Champaign, IL, Human Kinetics PressMalina RM, Bouchard C, Bar-Or O , second 2004, 623-49.
2. American Academy of Pediatrics Committee on Sports Medicine and Fitness: Use of performance-enhancing substances. Pediatrics 2005, 115:1103-6.
3. Cryer PE: Glucose homeostasis and hypoglycaemia. Williams Textbook of Endocrinology Saunders/Elsevier, PhiladelphiaKronenberg HM, Melmed S, Polonsky KS, Larsen PR , 11 2008, 1503-1534.
4. Ho RC, Alcazar O, Goodyer LJ: Exercise regulation of insulin action in skeletal muscle. The Endocrine System in Sports and Exercise. in collaboration with The International Federation of Sports Medicine Blackwell Publishing, Oxford, UKKraemer WJ, Rogol AD 2005, 388-407.
5. Thevis M, Thomas A, Schänzer W: Insulin. Handb Exp Pharmacol 2009, 195:209-26.
6. Veldhuis JD, Roemmich JN, Richmond EJ, Rogol AD, Lovejoy JC, Sheffield-Moore M, Mauras N, Bowers CY: Endocrine control of body composition in infancy, childhood, and puberty. Endocr Rev 2005, 26:114-46.
7. Holland-Hall C: Performance-enchancing substances: is your adolescent patient using?. Pediatr Clin N Am 2007, 54:651-62.
8. Carpenter PC: Performance-enhancing drugs in sport. Endocrinol Metab Clin N Amer 2007, 36:481-95.
9. Castillo EM, Comstock RD: Prevalence of use of performance-enhancing substances among United States adolescents. Pediatr Clin N Amer 2007, 54:66-75.
10. Rogol AD: Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent?. Growth Hormone and IGF Res 2009, 19:294-299.
11. Graham MR, Baker JS, Evans A, Kicman D, Cowan D, Hullin D, Thomas N, Bavies B: Physical effect of short-term recombinant human growth hormone administration in abstinent steroid dependency. Hormone Res 2008, 69:343-354.
12. Bidlingmaier M, Strasburger CJ: Technology insight: Detecting growth hormone abuse in athletes. Nat Clin Pract Endocinol Metab 2007, 3:769-777.
13. Healy ML, Dall R, Gibney J, Bassett E, Ehrnborg C, Pentecost C, Rosen T, Cittadini A, Baxter RC, Sonksen PH: Toward the development of a test for growth hormone (GH) abuse: A study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting. J Clin Endocrinol Metab 2005, 90:641-649.
14. Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE, GH Insensitivity Syndrome Collaborative Group: Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab 2007, 92:902-10.
15. Pollak M: Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008, 8(12):915-28.
16. Guha N, Sonksen PH, Holt RIG: IGF-I abuse in sport: Current knowledge and future prospects for detection. Growth hormone & IGF Research 2009, 19:408-411.
17. Elliott S: Erythropoiesis-stimulating agents and other methods to enhance oxygen transport. Brit J Pharmacol 2008, 154:529-41.
18. Bidlingmaier M, Wu Z, Strasburger CJ: Measurement of Peptide hormones. The Endocrine System in Sports and Exercise. in collaboration with The International Federation of Sports Medicine Blackwell Publishing, Oxford, UKKraemer WJ, Rogol AD 2005, 36-46.
19. Hoffman JR, Kraemer WJ, Bhassin S, Storer T, Ratamess NA, Haff G, Willoughby DS, Rogol AD: Position stand on Androgen and human growth hormone use (National Strength and Conditioning Association). J Strength Cont Res 2009, 23(5 Supp):S1-S59.
20. Spiering BA, Kraemer WJ, Vingren JL, Ratamess NA, Anderson JM, Armstrong LE, Nindl BC, Volek JS, Häkkinen K, Maresh CM: Elevated endogenous testosterone concentrations potentiate muscle androgen receptor responses to resistance exercise. J Steroid Biochem Mol Biol 2009, 114:195-9.
21. Takeda H, Chodak G, Mutchnik S, Nakamoto T, Chang C: Immunohistochemical localization of androgen receptors with monoand polyclonal antibodies to androgen receptor. J Endocrinol 1990, 126:17-25.
22. Thevis M, Schanzer W: Analysis of low molecular weight substances in doping control. The Endocrine System in Sports and Exercise.in collaboration with The International Federation of Sports Medicine Blackwell Publishing, Oxford, UKKraemer WJ, Rogol AD 2005, 47-68.